White Papers
-
DLBCL Asia-Pacific Insights And Experiences
6/21/2023
Get an overview of trends and insights into the current development of DLBCL clinical trials in the APAC and excerpts from an expert panel discussion from eight APAC countries.
-
Unlocking Europe's Commercial Potential For Biopharma Startups
6/21/2023
Dive into this compelling case for launching emerging biopharma in Europe and how to succeed.
-
Mitigating CAR Risks In Autologous CAR-T Therapy Trials In Oncology
6/21/2023
Developed from a clinical trial perspective, consider these practices when managing toxicities associated with autologous Chimeric Antigen Receptor T-cell (CAR-T) therapies among patients with B-cell hematologic malignancies.
-
Digital Transformation: A Critical Component For CDMOs
6/21/2023
Learn how embracing the digital transformation is key for managing complexity of speed, service, quality, regulatory compliance, and capacity as well as the obstacles facing CDMOs looking to innovate.
-
The Shifting Paradigm Of Dose Selection In Oncology
6/21/2023
Oncology drug development is undergoing a significant transformation. Explore strategies for integrating dose finding and optimization into early clinical development and how it could benefit oncology patients.
-
Improving CAR-T Trial Success With Historical Trial Data Optimization
6/19/2023
Breakthroughs in oncology have revolutionized patient care. Dive into treatment access, challenges faced in clinical development, and how data can be utilized to accelerate clinical development.
-
Increasing Access To CAR-T Therapy Trifecta: Safety, Efficacy, & Cost
6/19/2023
Review the history and current landscape of CAR T-cell therapy research and development to gain insight from strategies used to increase safety and efficacy while lowering cost.
-
Improving Diversity Data In Clinical Trial Benchmarking & Feasibility
6/15/2023
Improving diversity representation in clinical trials relies on demographic data. Get a glimpse of the problems sponsors encounter when obtaining this data and how regulatory agencies are working to ensure its accessibility.
-
2022 Completed Trials: A Roller Coaster Ride For Industry Sponsors
6/15/2023
Dive into this analysis to better understand why the clinical trials landscape has not returned to its pre-pandemic level of momentum.
-
Making Clinical Research Better For Patients With Patient Centricity By Design
6/13/2023
Discover why many sponsors struggle to design and conduct studies that accommodate the perspectives and preferences of patients and caregivers.